2026 · Poster Presentation · Poster Presentation · Gastroenterology
17
Total Publications
5
Abstract/Manuscript
1
Oral Presentation
11
Poster Presentation
2026 · Poster Presentation · Poster Presentation · Gastroenterology
Characterization and Impact of Upadacitinib on patients with Fistulizing Crohn’s Disease in the Real World: Findings from TARGET-GASTRO.
Read more →2026 · Poster Presentation · Poster Presentation · Gastroenterology
Impact Of Early Endoscopic Remission After Advanced Therapy On Long-Term Complications In Crohn's Disease: Findings From TARGET-IBD.
Read more →2024 · Abstract/Manuscript · Abstract/Manuscript
Factors Predicting Loss of Remission in Crohn’s Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD.
Read more →2023 · Abstract/Manuscript · Abstract/Manuscript
Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease.
Read more →2022 · Poster Presentation · AIBD Conference · Gastroenterology
The Impact of Early vs. Late Biologic Initiation Among Real World Patients with Crohn’s Disease in TARGET IBD.
Read more →2022 · Abstract/Manuscript · Abstract/Manuscript
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET‑IBD.
Read more →2021 · Poster Presentation · Poster Presentation · Gastroenterology
Histological Inflammation Predicts Loss of Remission Among Crohn’s Patients with Endoscopic Remission: A US Cohort Analysis.
Read more →2021 · Poster Presentation · Poster Presentation · Gastroenterology
Immunomodulators are Commonly Used as Concomitant Therapy with Vedolizumab or Ustekinumab: TARGET-IBD Real World Cohort.
Read more →2021 · Poster Presentation · Poster Presentation · Gastroenterology
Biologic-naïve Patients with Crohn’s Disease are More Likely to Achieve Mucosal Healing than Biologic-experienced Patients: TARGET-IBD Real World Cohort.
Read more →2021 · Abstract/Manuscript · Abstract/Manuscript
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease.
Read more →2021 · Abstract/Manuscript · Abstract/Manuscript
Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD.
Read more →2020 · Poster Presentation · AIBD Conference · Gastroenterology
Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD.
Read more →2020 · Oral Presentation · Oral Presentation · Gastroenterology
Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD.
Read more →2020 · Poster Presentation · Care · Gastroenterology
Oral Mesalamine Use in Crohn’s Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study.
Read more →2019 · Poster Presentation · Care · Gastroenterology
Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study.
Read more →2018 · Poster Presentation · Poster Presentation · Gastroenterology
